Endometrial carcinoma with laparotomy wound recurrence:: complete remission following surgery and chemotherapy consisting of paclitaxel and carboplatin

被引:7
|
作者
Gücer, F [1 ]
Oz-Puyan, F
Yilmaz, Ö
Mülayim, N
Balkanli-Kaplan, P
Yüce, MA
机构
[1] Trakya Univ, Fac Med, Dept Obstet & Gynecol, TR-22030 Edirne, Turkey
[2] Trakya Univ, Fac Med, Dept Pathol, Edirne, Turkey
[3] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA
关键词
chemotherapy; endometrial carcinoma; incisional recurrence; laparotomy wound recurrence; paclitaxel; prognosis;
D O I
10.1111/j.1525-1438.2005.00179.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We present a patient with surgical stage I endometrial cancer who experienced laparotomy wound recurrence 4 years after primary treatment. She was treated successfully by complete surgical resection of recurrent tumors and chemotherapy. A 62-year-old white female with laparotomy wound recurrence of endometrial carcinoma with small-bowel involvement and concomitant subcutaneous metastasis in the abdominal wall underwent complete surgical resection of metastatic tumors followed by six cycles of chemotherapy consisting of paclitaxel (175 mg/m(2)) and carboplatin (area under the curve 5). Since 24 months after resection of recurrence, she has no evidence of disease recurrence. Endometrial carcinoma with laparotomy wound recurrences, especially those with concomitant metastases, can be successfully treated by complete surgical resection followed by chemotherapy consisting of paclitaxel and carboplatin.
引用
收藏
页码:1195 / 1198
页数:4
相关论文
共 23 条
  • [1] Complete remission of an endometrial carcinoma with bilateral multiple pulmonary and extrapelvic metastases treated by surgery and chemotherapy consisting of paclitaxel and carboplatin
    Gücer, F
    Yilmaz, Ö
    Balkanli-Kaplan, P
    Yüce, MA
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (06) : 1160 - 1162
  • [2] Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy
    Micha, John P.
    Sassoon, Aaron F.
    Wong, Humberto
    Goldstein, Bram H.
    ANTI-CANCER DRUGS, 2015, 26 (07) : 793 - 796
  • [3] Complete remission of uterine endometrial cancer with multiple lung metastases treated by paclitaxel and carboplatin
    Niwa K.
    Kometani K.
    Sekiya T.
    Nakazawa K.
    Kanakura Y.
    International Journal of Clinical Oncology, 2002, 7 (3) : 197 - 200
  • [4] Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
    Fujiwara, Kazuko
    Egawa-Takata, Tomomi
    Ueda, Yutaka
    Kimura, Toshihiro
    Yoshino, Kiyoshi
    Fujita, Masami
    Miyatake, Takashi
    Ohta, Yukinobu
    Kamiura, Shoji
    Enomoto, Takayuki
    Kimura, Tadashi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (05) : 1447 - 1453
  • [5] Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
    Kazuko Fujiwara
    Tomomi Egawa-Takata
    Yutaka Ueda
    Toshihiro Kimura
    Kiyoshi Yoshino
    Masami Fujita
    Takashi Miyatake
    Yukinobu Ohta
    Shoji Kamiura
    Takayuki Enomoto
    Tadashi Kimura
    Archives of Gynecology and Obstetrics, 2012, 285 : 1447 - 1453
  • [6] Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy
    Egawa-Takata, Tomomi
    Ueda, Yutaka
    Kuragaki, Chie
    Miyake, Takahito
    Miyatake, Takashi
    Fujita, Masami
    Yoshino, Kiyoshi
    Nakashima, Ryuichi
    Okazawa, Mika
    Tsutsui, Tateki
    Morishige, Ken-Ichirou
    Kimura, Tadashi
    Yamasaki, Masato
    Nishizaki, Takamichi
    Nagamatsu, Masaaki
    Ito, Kimihiko
    Asada, Masahiro
    Ogita, Kazuhide
    Wakimoto, Akinori
    Yamamoto, Toshiya
    Nishio, Yukihiro
    Enomoto, Takayuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1603 - 1610
  • [7] Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy
    Tomomi Egawa-Takata
    Yutaka Ueda
    Chie Kuragaki
    Takahito Miyake
    Takashi Miyatake
    Masami Fujita
    Kiyoshi Yoshino
    Ryuichi Nakashima
    Mika Okazawa
    Tateki Tsutsui
    Ken-Ichirou Morishige
    Tadashi Kimura
    Masato Yamasaki
    Takamichi Nishizaki
    Masaaki Nagamatsu
    Kimihiko Ito
    Masahiro Asada
    Kazuhide Ogita
    Akinori Wakimoto
    Toshiya Yamamoto
    Yukihiro Nishio
    Takayuki Enomoto
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1603 - 1610
  • [8] Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes
    Fader, Amanda Nickles
    Nagel, Christa
    Axtell, Allison E.
    Zanotti, Kristine M.
    Kelley, Joseph L.
    Moore, Kathleen N.
    Secord, Angeles Alvarez
    Walsh, Christine S.
    Huh, Warner K.
    Gehrig, Paola A.
    Gibbons, Heidi
    Rose, Peter G.
    Havrilesky, Laura J.
    Tuller, Erin
    Drake, Richard D.
    Bottsford-Miller, Justin
    O'Malley, David M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 558 - 562
  • [9] Sustained complete remission of stage IV carcinoma of the pyriform fossa following chemotherapy
    Amin, R
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2002, 116 (02) : 143 - 145
  • [10] Complete remission of ovarian endometrioid adenocarcinoma associated with hyperamylasemia and liver metastasis treated by paclitaxel and carboplatin chemotherapy: a case report
    Tohya, T
    Shimajiri, S
    Onoda, C
    Yoshimura, T
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (02) : 378 - 380